Chinese General Practice ›› 2023, Vol. 26 ›› Issue (03): 335-342.DOI: 10.12114/j.issn.1007-9572.2022.0276
Special Issue: 心力衰竭最新文章合辑; 心血管最新文章合辑; 营养最新文章合辑; 老年问题最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2022-05-11
Revised:
2022-07-21
Published:
2023-01-20
Online:
2022-09-01
Contact:
CHEN Ying
About author:
通讯作者:
陈莹
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0276
项目 | 无营养不良风险组(n=42) | 低营养不良风险组(n=181) | 中高营养不良风险组(n=156) | 检验统计量值 | P值 | |
---|---|---|---|---|---|---|
年龄〔M(P25,P75),岁〕 | 83.0(77.6,89.3) | 86.0(81.0,90.0)d | 89.0(85.0,92.0)de | 24.004c | <0.001 | |
年龄分布 | ||||||
60~80〔n(%),岁〕 | 17.0(40.5) | 44(24.3)d | 18(11.5)de | 19.316a | <0.001 | |
81~100〔n(%),岁〕 | 25.0(59.5) | 137(75.7)d | 138(88.5)de | |||
性别(男/女) | 19/23 | 123/58d | 124/32de | 19.372a | <0.001 | |
BMI( | 25.54±3.07 | 24.37±3.79d | 23.11±4.02de | 6.799b | 0.001 | |
卧床〔n(%)〕 | 4.0(9.5) | 16.0(8.8) | 49.0(31.4)de | 31.054a | <0.001 | |
住院时间〔M(P25,P75),d〕 | 10.0(7.0,12.0) | 11.0(8.0,14.0)d | 14.0(10.3,19.0)de | 38.843c | <0.001 | |
NYHA分级〔n(%)〕 | 37.051a | <0.001 | ||||
Ⅱ级 | 32.0(76.2) | 113.0(62.4)d | 54.0(34.6)de | — | — | |
Ⅲ级 | 90.0(21.4) | 54.0(29.8)d | 80.0(51.3)de | — | — | |
Ⅳ级 | 1.0(2.4) | 14.0(7.7)d | 22.0(14.1)de | — | — | |
合并疾病〔n(%)〕 | ||||||
高血压 | 37.0(88.1) | 154.0(85.1) | 134.0(85.9) | 0.258a | 0.879 | |
糖尿病 | 25.0(59.5) | 114.0(63.0) | 97.0(62.2) | 0.175a | 0.916 | |
心房颤动 | 12.0(28.6) | 61.0(33.7) | 64.0(41.0) | 3.122a | 0.210 | |
慢性肾脏病 | 5.0(11.9) | 63.0(34.8)d | 68.0(43.6)d | 14.614a | 0.001 | |
陈旧性心肌梗死 | 9.0(21.4) | 38.0(21.0) | 50.0(32.1)de | 5.809a | 0.055 | |
慢性阻塞性肺疾病 | 10.0(23.8) | 39.0(21.5) | 43.0(27.6) | 1.656a | 0.437 | |
肿瘤 | 1.0(2.4) | 28.0(15.5)d | 31.0(19.9)d | 7.631a | 0.022 | |
药物应用〔n(%)〕 | ||||||
他汀类药物 | 31.0(73.8) | 133.0(73.5) | 99.0(63.5) | 4.394a | 0.111 | |
生化指标 | ||||||
血红蛋白〔M(P25,P75),g/L〕 | 132.0(122.8,140.3) | 124.0(111.0,133.0)d | 109.0(97.0,127.0)de | 49.562c | <0.001 | |
淋巴细胞〔M(P25,P75),×109/L〕 | 1.98(1.66,2.24) | 1.43(1.11,1.80)d | 1.23(0.94,1.49)de | 58.625c | <0.001 | |
血钾( | 4.03±0.29 | 4.05±0.39 | 4.09±0.44 | 0.599b | 0.550 | |
血钠〔M(P25,P75),mmol/L〕 | 140.00(138.00,141.07) | 140.00(138.00,142.00) | 139.00(136.32,141.00)e | 6.204c | 0.045 | |
空腹血糖〔M(P25,P75),mmol/L〕 | 5.44(4.85,7.02) | 5.72(4.88,6.80) | 5.42(4.69,6.67) | 2.904c | 0.234 | |
尿素氮〔M(P25,P75),mmol/L〕 | 5.45(4.35,7.13) | 6.60(5.20,8.45)d | 7.20(5.30,9.75)de | 15.658c | <0.001 | |
肌酐〔M(P25,P75),μmol/L〕 | 76.25(65.80,90.85) | 85.90(70.95,180.00)d | 93.85(72.85,127.13)de | 13.514c | 0.001 | |
总蛋白( | 68.12±5.11 | 63.34±6.97d | 60.17±7.14de | 24.346b | <0.001 | |
血清白蛋白( | 38.70±2.66 | 36.83±3.28d | 31.39±3.24de | 155.901b | <0.001 | |
三酰甘油〔M(P25,P75),mmol/L〕 | 1.46(1.10,2.01) | 1.09(0.82,1.40)d | 0.75(0.59,0.75)de | 60.147c | <0.001 | |
总胆固醇〔M(P25,P75),mmol/L〕 | 4.74(3.97,5.36) | 3.58(3.12,4.43)d | 3.21(2.69,3.66)de | 82.847c | <0.001 | |
低密度脂蛋白胆固醇〔M(P25,P75),mmol/L〕 | 2.94(2.34,3.51) | 1.94(1.54,2.48)d | 1.67(1.34,2.03)de | 74.269c | <0.001 | |
高密度脂蛋白胆固醇〔M(P25,P75),mmol/L〕 | 1.05(0.95,1.49) | 1.06(0..87,1.34) | 1.05(0.76,1.23) | 5.274c | 0.072 | |
糖化血红蛋白〔M(P25,P75),%〕 | 6.40(5.90,7.90) | 6.30(5.85,7.25) | 6.10(5.70,7.00) | 4.158c | 0.125 | |
BNP〔M(P25,P75),mmol/L〕 | 132.00(60.00,227.00) | 157.00(75.00,295.00)d | 311.50(130.25,580.50)de | 38.160c | <0.001 | |
左心室射血分数〔M(P25,P75),%〕 | 61.00(58.00,65.00) | 62.00(57.50,64.00) | 60.00(55.00,65.00) | 4.528c | 0.104 | |
GNRI( | 106.19±6.55 | 101.06±9.26d | 89.48±10.66de | 65.538b | <0.001 | |
PNI( | 48.78±3.83 | 44.43±3.89d | 37.80±4.14de | 179.977b | <0.001 | |
1年内因HF再入院〔n(%)〕 | 9.00(21.4) | 32.00(17.7) | 56.00(35.9)de | 15.033a | 0.001 | |
1年内HF全因死亡〔n(%)〕 | 0 | 14.00(7.7)d | 62.00(39.7)de | 65.394a | <0.001 |
Table 1 Demographic and clinical indicators among older patients with HFpEF and coronary heart diseases according to the CONUT score
项目 | 无营养不良风险组(n=42) | 低营养不良风险组(n=181) | 中高营养不良风险组(n=156) | 检验统计量值 | P值 | |
---|---|---|---|---|---|---|
年龄〔M(P25,P75),岁〕 | 83.0(77.6,89.3) | 86.0(81.0,90.0)d | 89.0(85.0,92.0)de | 24.004c | <0.001 | |
年龄分布 | ||||||
60~80〔n(%),岁〕 | 17.0(40.5) | 44(24.3)d | 18(11.5)de | 19.316a | <0.001 | |
81~100〔n(%),岁〕 | 25.0(59.5) | 137(75.7)d | 138(88.5)de | |||
性别(男/女) | 19/23 | 123/58d | 124/32de | 19.372a | <0.001 | |
BMI( | 25.54±3.07 | 24.37±3.79d | 23.11±4.02de | 6.799b | 0.001 | |
卧床〔n(%)〕 | 4.0(9.5) | 16.0(8.8) | 49.0(31.4)de | 31.054a | <0.001 | |
住院时间〔M(P25,P75),d〕 | 10.0(7.0,12.0) | 11.0(8.0,14.0)d | 14.0(10.3,19.0)de | 38.843c | <0.001 | |
NYHA分级〔n(%)〕 | 37.051a | <0.001 | ||||
Ⅱ级 | 32.0(76.2) | 113.0(62.4)d | 54.0(34.6)de | — | — | |
Ⅲ级 | 90.0(21.4) | 54.0(29.8)d | 80.0(51.3)de | — | — | |
Ⅳ级 | 1.0(2.4) | 14.0(7.7)d | 22.0(14.1)de | — | — | |
合并疾病〔n(%)〕 | ||||||
高血压 | 37.0(88.1) | 154.0(85.1) | 134.0(85.9) | 0.258a | 0.879 | |
糖尿病 | 25.0(59.5) | 114.0(63.0) | 97.0(62.2) | 0.175a | 0.916 | |
心房颤动 | 12.0(28.6) | 61.0(33.7) | 64.0(41.0) | 3.122a | 0.210 | |
慢性肾脏病 | 5.0(11.9) | 63.0(34.8)d | 68.0(43.6)d | 14.614a | 0.001 | |
陈旧性心肌梗死 | 9.0(21.4) | 38.0(21.0) | 50.0(32.1)de | 5.809a | 0.055 | |
慢性阻塞性肺疾病 | 10.0(23.8) | 39.0(21.5) | 43.0(27.6) | 1.656a | 0.437 | |
肿瘤 | 1.0(2.4) | 28.0(15.5)d | 31.0(19.9)d | 7.631a | 0.022 | |
药物应用〔n(%)〕 | ||||||
他汀类药物 | 31.0(73.8) | 133.0(73.5) | 99.0(63.5) | 4.394a | 0.111 | |
生化指标 | ||||||
血红蛋白〔M(P25,P75),g/L〕 | 132.0(122.8,140.3) | 124.0(111.0,133.0)d | 109.0(97.0,127.0)de | 49.562c | <0.001 | |
淋巴细胞〔M(P25,P75),×109/L〕 | 1.98(1.66,2.24) | 1.43(1.11,1.80)d | 1.23(0.94,1.49)de | 58.625c | <0.001 | |
血钾( | 4.03±0.29 | 4.05±0.39 | 4.09±0.44 | 0.599b | 0.550 | |
血钠〔M(P25,P75),mmol/L〕 | 140.00(138.00,141.07) | 140.00(138.00,142.00) | 139.00(136.32,141.00)e | 6.204c | 0.045 | |
空腹血糖〔M(P25,P75),mmol/L〕 | 5.44(4.85,7.02) | 5.72(4.88,6.80) | 5.42(4.69,6.67) | 2.904c | 0.234 | |
尿素氮〔M(P25,P75),mmol/L〕 | 5.45(4.35,7.13) | 6.60(5.20,8.45)d | 7.20(5.30,9.75)de | 15.658c | <0.001 | |
肌酐〔M(P25,P75),μmol/L〕 | 76.25(65.80,90.85) | 85.90(70.95,180.00)d | 93.85(72.85,127.13)de | 13.514c | 0.001 | |
总蛋白( | 68.12±5.11 | 63.34±6.97d | 60.17±7.14de | 24.346b | <0.001 | |
血清白蛋白( | 38.70±2.66 | 36.83±3.28d | 31.39±3.24de | 155.901b | <0.001 | |
三酰甘油〔M(P25,P75),mmol/L〕 | 1.46(1.10,2.01) | 1.09(0.82,1.40)d | 0.75(0.59,0.75)de | 60.147c | <0.001 | |
总胆固醇〔M(P25,P75),mmol/L〕 | 4.74(3.97,5.36) | 3.58(3.12,4.43)d | 3.21(2.69,3.66)de | 82.847c | <0.001 | |
低密度脂蛋白胆固醇〔M(P25,P75),mmol/L〕 | 2.94(2.34,3.51) | 1.94(1.54,2.48)d | 1.67(1.34,2.03)de | 74.269c | <0.001 | |
高密度脂蛋白胆固醇〔M(P25,P75),mmol/L〕 | 1.05(0.95,1.49) | 1.06(0..87,1.34) | 1.05(0.76,1.23) | 5.274c | 0.072 | |
糖化血红蛋白〔M(P25,P75),%〕 | 6.40(5.90,7.90) | 6.30(5.85,7.25) | 6.10(5.70,7.00) | 4.158c | 0.125 | |
BNP〔M(P25,P75),mmol/L〕 | 132.00(60.00,227.00) | 157.00(75.00,295.00)d | 311.50(130.25,580.50)de | 38.160c | <0.001 | |
左心室射血分数〔M(P25,P75),%〕 | 61.00(58.00,65.00) | 62.00(57.50,64.00) | 60.00(55.00,65.00) | 4.528c | 0.104 | |
GNRI( | 106.19±6.55 | 101.06±9.26d | 89.48±10.66de | 65.538b | <0.001 | |
PNI( | 48.78±3.83 | 44.43±3.89d | 37.80±4.14de | 179.977b | <0.001 | |
1年内因HF再入院〔n(%)〕 | 9.00(21.4) | 32.00(17.7) | 56.00(35.9)de | 15.033a | 0.001 | |
1年内HF全因死亡〔n(%)〕 | 0 | 14.00(7.7)d | 62.00(39.7)de | 65.394a | <0.001 |
变量 | 单因素分析 | 多因素分析 | |||||
---|---|---|---|---|---|---|---|
OR(95%CI) | β | P值 | OR(95%CI) | β | P值 | ||
年龄 | 1.035(1.001,1.069) | 0.034 | 0.042 | — | — | — | |
卧床 | 0.532(0.305,0.930) | -0.630 | 0.027 | — | — | — | |
住院时间 | 1.029(1.001,1.056) | 0.028 | 0.038 | — | — | — | |
NYHA | — | — | — | ||||
Ⅱ级 | 1 | — | — | — | |||
Ⅲ级 | 2.021(1.213,3.339) | 0.699 | 0.007 | — | — | — | |
Ⅳ级 | 3.849(1.835,8.070) | 1.348 | <0.001 | — | — | — | |
合并慢性肾脏病 | 0.618(0.386,0.990) | -0.481 | 0.045 | — | — | — | |
血红蛋白 | 0.979(0.966,0.992) | -0.021 | 0.001 | — | — | — | |
尿素氮 | 1.079(1.025,1.137) | 0.076 | 0.004 | — | — | — | |
肌酐 | 1.008(1.004,1.013) | 0.008 | <0.001 | 1.009(1.003,1.015) | 0.009 | 0.004 | |
血糖 | 0.884(0.772,1.013) | -0.123 | 0.076 | — | — | — | |
血清白蛋白 | 0.899(0.849,0.951) | -0.107 | <0.001 | — | — | — | |
三酰甘油 | 0.649(0.428,0.985) | -0.432 | 0.042 | — | — | — | |
糖化血红蛋白 | 0.866(0.702,1.068) | -0.144 | 0.179 | — | — | — | |
BNP | 1.001(1.000,1.001) | 0.001 | 0.006 | 1.001(1.000,1.002) | 0.001 | 0.018 | |
左心室射血分数 | 0.933(0.888,0.930) | -0.069 | 0.006 | — | — | — | |
GNRI | 0.972(0.949,0.995) | -0.029 | 0.016 | — | — | — | |
CONUT评分 | 1.236(1.121,1.363) | 0.212 | <0.001 | — | — | — | |
PNI | 0.927(0.887,0.969) | -0.076 | 0.001 | — | — | — |
Table 2 Univariable and multivariable analyses of factors predicting HF-related readmission in elderly patients with HFpEF and coronary heart disease within 1 year after discharge
变量 | 单因素分析 | 多因素分析 | |||||
---|---|---|---|---|---|---|---|
OR(95%CI) | β | P值 | OR(95%CI) | β | P值 | ||
年龄 | 1.035(1.001,1.069) | 0.034 | 0.042 | — | — | — | |
卧床 | 0.532(0.305,0.930) | -0.630 | 0.027 | — | — | — | |
住院时间 | 1.029(1.001,1.056) | 0.028 | 0.038 | — | — | — | |
NYHA | — | — | — | ||||
Ⅱ级 | 1 | — | — | — | |||
Ⅲ级 | 2.021(1.213,3.339) | 0.699 | 0.007 | — | — | — | |
Ⅳ级 | 3.849(1.835,8.070) | 1.348 | <0.001 | — | — | — | |
合并慢性肾脏病 | 0.618(0.386,0.990) | -0.481 | 0.045 | — | — | — | |
血红蛋白 | 0.979(0.966,0.992) | -0.021 | 0.001 | — | — | — | |
尿素氮 | 1.079(1.025,1.137) | 0.076 | 0.004 | — | — | — | |
肌酐 | 1.008(1.004,1.013) | 0.008 | <0.001 | 1.009(1.003,1.015) | 0.009 | 0.004 | |
血糖 | 0.884(0.772,1.013) | -0.123 | 0.076 | — | — | — | |
血清白蛋白 | 0.899(0.849,0.951) | -0.107 | <0.001 | — | — | — | |
三酰甘油 | 0.649(0.428,0.985) | -0.432 | 0.042 | — | — | — | |
糖化血红蛋白 | 0.866(0.702,1.068) | -0.144 | 0.179 | — | — | — | |
BNP | 1.001(1.000,1.001) | 0.001 | 0.006 | 1.001(1.000,1.002) | 0.001 | 0.018 | |
左心室射血分数 | 0.933(0.888,0.930) | -0.069 | 0.006 | — | — | — | |
GNRI | 0.972(0.949,0.995) | -0.029 | 0.016 | — | — | — | |
CONUT评分 | 1.236(1.121,1.363) | 0.212 | <0.001 | — | — | — | |
PNI | 0.927(0.887,0.969) | -0.076 | 0.001 | — | — | — |
变量 | 单因素分析 | 多因素分析 | |||||
---|---|---|---|---|---|---|---|
OR(95%CI) | β | P值 | OR(95%CI) | β | P值 | ||
年龄 | 1.061(1.020,1.103) | 0.059 | 0.003 | — | — | — | |
BMI | 0.911(0.839,0.990) | -0.093 | 0.027 | — | — | — | |
卧床 | 0.246(0.139,0.436) | -1.4 | <0.001 | — | — | — | |
住院时间 | 1.109(1.064,1.115) | 0.103 | <0.001 | — | — | — | |
NYHA | — | — | — | ||||
Ⅱ级 | 1 | — | — | — | |||
Ⅲ级 | 2.769(1.564,4.904) | 1.019 | <0.001 | — | — | — | |
Ⅳ级 | 5.217(2.375,11.463) | 1.652 | <0.001 | — | — | — | |
血红蛋白 | 0.966(0.952,0.980) | -0.035 | <0.001 | — | — | — | |
淋巴细胞 | 0.495(0.299,0.821) | -0.703 | 0.006 | — | — | — | |
血钠 | 0.934(0.872,1.002) | -0.068 | 0.055 | — | — | — | |
总蛋白 | 0.956(0.922,0.992) | -0.044 | 0.017 | — | — | — | |
血清白蛋白 | 0.805(0.750,0.864) | -0.217 | <0.001 | — | — | — | |
三酰甘油 | 0.663(0.420,1.048) | -0.411 | 0.079 | — | — | — | |
BNP | 1.001(1.001,1.002) | 0.001 | <0.001 | 1.001(1.000,1.002) | 0.002 | 0.012 | |
左心室射血分数 | 0.928(0.880,0.979) | -0.075 | 0.007 | — | — | — | |
GNRI | 0.939(0.912,0.967) | -0.063 | <0.001 | — | — | — | |
CONUT评分 | 1.644(1.392,1.943) | 0.497 | <0.001 | 1.567(1.302,1.885) | 0.449 | <0.001 | |
PNI | 0.084(0.796,0.890) | -0.173 | <0.001 | — | — | — |
Table 3 Univariable and multivariable analyses of factors predicting all-cause mortality in elderly patients with HFpEF and coronary heart diseases within 1 year after discharge
变量 | 单因素分析 | 多因素分析 | |||||
---|---|---|---|---|---|---|---|
OR(95%CI) | β | P值 | OR(95%CI) | β | P值 | ||
年龄 | 1.061(1.020,1.103) | 0.059 | 0.003 | — | — | — | |
BMI | 0.911(0.839,0.990) | -0.093 | 0.027 | — | — | — | |
卧床 | 0.246(0.139,0.436) | -1.4 | <0.001 | — | — | — | |
住院时间 | 1.109(1.064,1.115) | 0.103 | <0.001 | — | — | — | |
NYHA | — | — | — | ||||
Ⅱ级 | 1 | — | — | — | |||
Ⅲ级 | 2.769(1.564,4.904) | 1.019 | <0.001 | — | — | — | |
Ⅳ级 | 5.217(2.375,11.463) | 1.652 | <0.001 | — | — | — | |
血红蛋白 | 0.966(0.952,0.980) | -0.035 | <0.001 | — | — | — | |
淋巴细胞 | 0.495(0.299,0.821) | -0.703 | 0.006 | — | — | — | |
血钠 | 0.934(0.872,1.002) | -0.068 | 0.055 | — | — | — | |
总蛋白 | 0.956(0.922,0.992) | -0.044 | 0.017 | — | — | — | |
血清白蛋白 | 0.805(0.750,0.864) | -0.217 | <0.001 | — | — | — | |
三酰甘油 | 0.663(0.420,1.048) | -0.411 | 0.079 | — | — | — | |
BNP | 1.001(1.001,1.002) | 0.001 | <0.001 | 1.001(1.000,1.002) | 0.002 | 0.012 | |
左心室射血分数 | 0.928(0.880,0.979) | -0.075 | 0.007 | — | — | — | |
GNRI | 0.939(0.912,0.967) | -0.063 | <0.001 | — | — | — | |
CONUT评分 | 1.644(1.392,1.943) | 0.497 | <0.001 | 1.567(1.302,1.885) | 0.449 | <0.001 | |
PNI | 0.084(0.796,0.890) | -0.173 | <0.001 | — | — | — |
Figure 1 ROC curve analysis of the CONUT score,GNRI and PNI in predicting readmission for HF in elderly patients with HFpEF and coronary heart diseases within 1 year after discharge
Figure 2 ROC curve analysis of the CONUT score,GNRI and PNI in predicting all-cause mortality in elderly patients with HFpEF and coronary heart diseases within 1 year after discharge
[1] |
World population prospects 2019[EB/OL].(2019-12-31)[2020-12-31].
|
[2] |
中国发展研究基金会. 中国老年人营养与健康报告[M]. 北京:中国发展出版社,2016.
|
[3] |
|
[4] |
王丹,郝瑞瑞,姜春燕. 老年住院患者营养状况对预后影响的临床观察[J]. 临床和实验医学杂志,2016,15(16):1571-1574. DOI:10.3969/J.ISSN.1671-4695.2016.16.007.
|
[5] |
|
[6] |
|
[7] |
|
[8] |
Editorial:Major changes made by Criteria Committee of the New York Heart Association[J]. Circulation,1974,49(3):390. DOI:10.1161/01.cir.49.3.390.
|
[9] |
|
[10] |
中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志,2018,46(10):760-789. DOI:10.3760/cma.j.issn.0253-3758.2018.10.004.
|
[11] |
中国超重/肥胖医学营养治疗专家共识编写委员会. 中国超重/肥胖医学营养治疗专家共识(2016年版)[J]. 糖尿病临床,2016,10(10):451-455. DOI:10.3969/j.issn.1672-7851.2016.10.003.
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[1] | ZHOU Qibao, LUO Xiao, CHEN Ling, CAO Junda, LI Juxiang, XU Jinsong, SU Hai. Clinical Study on the Diagnostic Value of Circadian Variability of Systolic Blood Pressure Combined with SDNN in Coronary Heart Disease [J]. Chinese General Practice, 2025, 28(30): 3760-3765. |
[2] | WU Wenjun, WEI Jingjing, LI Xue, REN Hongjie, YU Rui, PENG Guangcao, ZHU Mingjun. Regularity of Prescriptions for Coronary Heart Disease with Hypertension Based on Latent Structure and Association Rules [J]. Chinese General Practice, 2025, 28(30): 3787-3795. |
[3] | MA Shuangshuang, XING Yanjiang, ZHANG Jiawei, WANG Jing. Research Progress on Cardiac Energy Metabolic Changes in Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2025, 28(30): 3831-3840. |
[4] | LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778. |
[5] | CHENG Yuxin, FANG Jiamin, LIANG Hao, WANG Zhiling, WEI Li, LIAO Huilian, XU Mingming, CHEN Yumei, LI Yanfen, DONG Lijuan, GUO Yingui. Preoperative Platelet-to-albumin Ratio in Elective Geriatric Surgery Patients and Its Correlation with Postoperative Incidental Frailty: a Multicenter Study [J]. Chinese General Practice, 2025, 28(27): 3359-3367. |
[6] | LIU Zhenyu, WEI Yunpeng, WANG Jiangmin, XING Yan. Causal Association Study between Sleep Duration and Heart Failure [J]. Chinese General Practice, 2025, 28(27): 3441-3446. |
[7] | XU Yanpeng, HUANG Pe, ZHANG Pingping, LUO Yan, SHI Xiaoqi, WU Liusong, CHEN Yan, HE Zhixu. Expression of β-Adrenergic Receptors in Acute T-cell Lymphoblastic Leukemia and Its Clinical Significance [J]. Chinese General Practice, 2025, 28(27): 3391-3398. |
[8] | LIU Wenjie, SUN Huang, LUO Wei, CHEN Xuan, PENG Yunzhu, LI Ruijie, MA Mier. Wearable Acoustic-electrocardiographic Remote Monitoring Device for Heart Failure [J]. Chinese General Practice, 2025, 28(25): 3104-3109. |
[9] | YAN Fanghong, PENG Guotian, ZHANG Guoli, SUN Ruiyi, MA Yuxia, HAN Lin. Matching Analysis of the Content of Chronic Disease Management for the Elderly in Medical Union: Based on the Perspective of "Guidance-Practice-Need" [J]. Chinese General Practice, 2025, 28(25): 3119-3126. |
[10] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[11] | HAN Bing, DU Shuzhen, MENG Xiaoxue, ZHANG Lu, CHEN Zixian, TENG Fengling. Plasma Periostin Levels Correlated with Myocardial Fibrosis in Patients with Heart Failure with Different Ejection Fraction [J]. Chinese General Practice, 2025, 28(24): 2979-2984. |
[12] | CHEN Fei, WANG Jinying, YU Haibo, LI Xin, ZHANG Jiajia, SHEN Man, ZHAN Xiaokai, TANG Ran, FAN Sibin, ZHAO Fengyi, ZHANG Tianyu, HUANG Zhongxia. Significance of Elevated Urinary NGAL, TIM-1, VCAM-1 and Activin A in Patients with New Diagnosed Multiple Myeloma [J]. Chinese General Practice, 2025, 28(22): 2740-2749. |
[13] | YANG Ji, ZHANG Yao, ZHAO Yingqiang, ZHANG Qiuyue. Evaluation of the Effectiveness of TCM Three-level Prevention and Control Model in the Management of Patients with Coronary Heart Disease and Stroke: a Single-center, Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(22): 2750-2761. |
[14] | DONG Haocheng, HAO Xiao, AN Dong, LI Haohan, LI Shuren. Research Progress of Heart Failure with Supra-normal Ejection Fraction [J]. Chinese General Practice, 2025, 28(21): 2692-2696. |
[15] | HE Ting, LI Jia, TAN Wenbin. Research Progress of Circulatory System Diseases and Secondary Osteoporosis [J]. Chinese General Practice, 2025, 28(17): 2101-2112. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||